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Abstract
Background: The literature indicates that chronic obstructive pulmonary disease (COPD) affects cardiac autonomic
control. In this study, we conducted a literature review in order to investigate the heart rate variability (HRV) in
COPD subjects.
Methods: A search was performed in Medline database, using the link between the keywords: “autonomic nervous
system”, “cardiovascular system”, “COPD” and “heart rate variability”.
Results: The search resulted in a total of 40 references. Amongst these references, the first exclusion resulted in the
barring of 29 titles and abstracts, which were not clearly related to the purpose of review. This resulted in a total of
11 articles that were then read and utilized in the review. The selected studies indicated that there is significant
reduction of HRV in patients with COPD, characterized by reduction of indices that assess parasympathetic activity
in addition to dealing with the global autonomic modulation. We also established that supervised exercise can
reduce these harmful effects in COPD patients. Also, it was reported that the use of non-invasive ventilation in these
patients may contribute to the improvement of respiratory symptoms, with no impairing, and may even induce
positive responses in cardiac autonomic regulation.
Conclusion: The studies indicate a need for further investigations to guide future therapies to improve the
treatment of cardiovascular system in the respiratory diseases.
Keywords: Autonomic nervous system, COPD, Heart rate variability, Cardiovascular system
Introduction
Chronic obstructive pulmonary disease (COPD) is defined
as a respiratory illness that can be prevented and treated.
COPD is characterized by chronic airflow obstruction
which is not fully reversible [1,2] and significant systemic
manifestations such as: nutritional depletion, structural
and functional alterations of the respiratory and peripheral
skeletal muscles and arrhythmia [3].
There are studies addressing changes in sympathetic-
vagal balance caused by cardiopulmonary diseases, such
as COPD. These could be identified by the presence of
harmful alterations in the autonomic nervous system
(ANS) function of subjects with COPD [4,5]. Because it
is a disease with high morbidity and mortality, and coex-
ists with cardiovascular disease, it is necessary a higher
level of care in these patients.
The heart rate variability (HRV) has been widely used
to assess the behavior of ANS, it is a noninvasive, inexpen-
sive, and can describe a phenomena related to ANS in
healthy and unhealthy subjects [6]. It is a conventionally
accepted term to describe the fluctuations in the intervals
between consecutive heartbeats (RR intervals), and is dir-
ectly related to the performance of the ANS on the sinusal
node [7]. It implies that an individual with low HRV has
greater pre-disposition to submit cardiovascular problems,
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under physiological conditions, the greater HRV, better
the health condition of the subject [8].
HRV analysis has been studied since 1965 and has been
increasingly emphasized for being an important method
for early diagnosis of cardiovascular diseases [6]. Previous
studies have indicated reduced HRV in patients with
COPD compared to healthy individuals of the same age
[4,9], showing inferior clinical prognosis of these indivi-
duals. Based on these concepts, the present study aimed
to investigate the relationship between COPD and HRV.
The purpose of this study was to investigate the
established results about “autonomic nervous system”,
“cardiovascular system” and “COPD”, and “Heart Rate
Variability” and “COPD” in previous studies.
Methods
Search strategy
All steps are presented in Figures 1 and 2. The review
was analyzed between March 2014 and May 2014. Data
from Medline (via PubMed), databases were searched
using the following keywords: “autonomic nervous sys-
tem”, “cardiovascular system” and “COPD”, and “Heart
Rate Variability” and “COPD”. These were defined by the
Medical Subject Headings (MeSH) in the National Li-
brary of Medicine.
Inclusion and exclusion criteria
We excluded studies that did not show full text or abstract
in English between 2009 and 2014 and review of literature
as well as summaries of academic Dissertations or Theses.
Inclusion criteria were considered clinical and basic
studies that investigated the behavior of the autonomic
nervous system in patients with chronic obstructive pul-
monary disease (COPD), published in the last 6 years.
Selection strategy
Initially a screening of titles was undertaken related to
the topic. This selection was based on evidence that re-
lated cardiac autonomic control (via heart rate variabi-
lity) with chronic obstructive pulmonary disease (COPD).
At the end of the study, we excluded duplications, as this
was done in several databases. Reading the detailed
summaries of articles in order to select those that ad-
dressed only the behavior of the autonomic nervous sys-
tem via some protocol in patients with COPD was
undertaken. We excluded abstracts not related to the
issue, the full texts were evaluated and those who did
not fit the exclusion criteria were included as the final
result of the research.
To increase confidence in the selection of articles, all
potentially relevant articles were reviewed independently
by two researchers, who after reading through all of
them, entered consensus to establish which articles ful-
filled the inclusion criteria [10].
Data analysis
Data was qualitatively evaluated and presented in tables
with a description of the following profile: author and
year of study and the main conclusions found by the au-
thors during the studies.
There are many scales that help the studies evaluation,
nowadays; the most used in rehabilitation area is the
PEDro [11] scale. This scale was developing by Physio-
therapy Evidence Database to be used in experimental
studies and has a total score of 10 points, including
evaluation criteria of internal validity and presentation
of statics analysis used [11].
In order to demonstrate the methodological quality of
the studies it was considered the article with good level
of evidence the one with score equal or higher than 6 ac-
cording with evaluation scale PEDro. This criterion was
based on Snider’s work [12], that consider studies scor-
ing 9-10 on the PEDro scale are methodologically ‘Excel-
lent’, 6-8 ‘Good’, 4-5 ‘Fair’ and below 4 ‘Poor’.
Results
The electronic search resulted in a total of 40 references.
Among these references, the first elimination resulted in
the exclusion of 29 titles and abstracts, which were not
clearly related to the purpose of review. It resulted in a
total of 11 articles that were then fully read and utilized
in the review.
Figure 1 Step by step showing the literature review.
Roque et al. International Archives of Medicine 2014, 7:43 Page 2 of 8
http://www.intarchmed.com/content/7/1/43
Initially, there were 40 studies found, of these 29 articles
were excluded to not fit the inclusion criteria (Figure 1).
The data extracted from the 11 eligible (Table 1).
Discussion
During the study of the articles used in the preparation
of this review, it was observed that patients with COPD
have reduced heart rate variability compared to healthy
patients. Moreover, some features, such as the non-
invasive ventilation can improve the cardiac autonomic
control of these individuals suggesting a reduction in the
impact of cardiac co-morbidities therein. In addition, we
verified that some studies have analyzed the effects of
exercises like strength and endurance exercises; six mi-
nute walk test or even through pulmonary rehabilitation,
and it was observed that all interventions improve heart
rate variability in COPD patients, which cautions us to
importance of physical exercise to improve the quality of
life of these population.
Heart rate variability has been used as a tool to analyze
the behavior of the autonomic nervous system on the
heart, and compare possible differences between healthy
and unhealthy people. Its decrease is related to increase
morbidity and mortality [24], which was confirmed the
data found in our research on COPD. Studies indicate
that there are changes in HRV in a list of cardiorespira-
tory disorders. COPD is associated with vascular remod-
eling that modifies the pulmonary circulation. This
pathological mechanism is usually caused by hypoxia
generated by the disease [25].
According to the study of REIS et al [21], both patients
with COPD and patients with congestive heart failure
(CHF), exhibit alterations in autonomic modulation of
heart rate at rest and during respiratory sinusal arrhythmia
maneuver (RSA-M) compared with apparently healthy in-
dividuals. During rest, patients with COPD showed a re-
duction in sympathetic activity compared to the control
group. Regarding the CHF it was also observed decreased
Figure 2 Flowchart of search strategy and selection process.
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sympathetic and parasympathetic activity of the subjects.
It was indicated a possible relationship to regulatory
changes of autonomic centers, the sensitivity of chemore-
ceptors or respiratory pattern characterized by periodic
oscillations presented by these patients. During the RSA-
M it was observed that both COPD patients and patients
with CHF, through the analysis of HRV indices in the time
domain (SDNN and rMSSD) and frequency domain (LF
and HF, both in units absolute) had reduced response, re-
vealing a decrease in HRV compared with control subjects.
These data presented in the study indicated that it is pos-
sible that reduced HRV observed in patients of both
groups may be related to changes in lung compliance and
response of lung receptors stretches.
A study of Mendes et al [18], evaluated the heart rate,
blood pressure and heart rate variability in test forced
Table 1 Main studies about the influences of chronic obstructive pulmonary disease on cardiac autonomic control
Selected articles Principal outcomes Score
Pedro
Van gestel et al.,
2011 [13]
We studied 60 patients with COPD and measured HRQL, as assessed by the Chronic Respiratory Disease
Questionnaire, and cardiac autonomic dysfunction, as assessed by heart rate variability (HRV). Analysis of HRV
was performed using a Holter-ECG device during a recording period of 5 min. To evaluate a possible association
between these factors, univariate and multivariate analyses were used. Resting parasympathetic tone, as measured
by HRV, is independently associated with HRQL, which emphasizes the role of cardiac autonomic dysfunction on
HRQL in patients with COPD.
3/10
Gunduz et al., 2009
[14]
Twenty five moderate to severe COPD patients and 25 healthy subjects were included in this study. Pulmonary
function tests and echocardiographic examination, arterial blood gases analysis were performed; HRV and HRT
analysis were assessed from a 24-hour Holter recording. In addition to HRV parameters, HRT onset was significantly
different in COPD patients. In our opinion, the combination of HRV variables and HRT onset may be simple and
elegant ways of evaluating cardiac autonomic functions.
3/10
Cheng et al., 2014
[15]
Sixty-four patients with COPD participated in a 12-week, 2 sessions-per-week, hospital-based PR program. Baseline
and post-PR status were evaluated by spirometry, HRV, health-related quality of life, cardiopulmonary exercise test,
respiratory muscle strength, and dyspnea Borg's scale. PR results in significant improvements in autonomic function,
with concurrent improvements in HRQL and exercise capacity.
4/10
Suh et al., 2013 [16] The study utilized a 2 (disease status) × 2 (anxiety group) factorial design examining HRV associated with anxiety
symptoms and COPD during a standardized acute social stress task. 30 COPD patients were age- and gender-matched
with 30 healthy controls. Anxiety is associated with dysregulated HRV response to a psychosocial stressor, but the
negative influence of anxiety and COPD on autonomic function did not appear to be additive. Comorbid anxiety in
patients with COPD is associated with increased behavioral and psychological symptoms of distress.
5/10
Dias de Carvalho
et al., 2011 [17]
We evaluated geometric index of HRV in COPD subjects. We analyzed data from 34 volunteers, divided into
two groups according to spirometric values: COPD and control. For analysis of HRV indexes the volunteers
remained in the supine position for 30 minutes. Subjects with COPD present reduction of geometric indexes of
HRV, indicating reduced heart rate variability.
6/10
Mendes et al., 2011
[18]
To analyze the behavior of heart rate (HR), blood pressure (BP) and heart rate variability (HRV) during the FVC
test in COPD patients. Nineteen men with COPD performed the FVC test while having their HR monitored. HRV
was assessed in time and frequency domains at rest, before and after the best FVC maneuver. BP was
measured at rest, immediately before and at the end of the test, as well as 10 minutes after the end of the test.
The FVC test influences the behavior of COPD patient HR without changing autonomic control or BP.
4/10
Camillo ca et al.,
2011 [19]
We aimed to investigate changes in HRV after two exercise training programs in patients with COPD. Forty
patients with COPD were randomized into high (n = 20) or low (n = 20) intensity exercise training (3-month
duration), and had their HRV assessed by the head-up tilt test before and after either protocols. High-intensity
exercise training improves HRV at rest and during orthostatic stimulus in patients with COPD.
5/10
Carvalho et al.,
2011 [20]
We analyzed data from 30 volunteers, who were divided into two groups according to spirometric values:
COPD (n = 15) and control (n = 15). For analysis of HRV indices, HRV was recorded beat by beat with the
volunteers in the supine position for 30 minutes. COPD subjects present reduced short-term fractal correlation
properties of HRV, which indicates that this index can be used for risk stratification, assessment of systemic
disease manifestations, and therapeutic procedures to monitor those patients.
5/10
Reis et al., 2010 [21] Ten COPD patients and nine age-matched healthy volunteers participated in this study. Heart-rate variability
(HRV) was obtained at rest and during respiratory sinusal arrhythmia maneuver (RSA-M) by electrocardiograph.
Patients with chronic obstructive pulmonary disease presented impaired sympathetic-vagal balance at rest. In
addition, cardiac autonomic control of heart rate was associated with inspiratory muscle weakness in chronic
obstructive pulmonary disease.
3/10
Borghi-Silva et al.,
2009 [22]
Forty patients of both sexes with moderate-to-severe COPD were randomly allocated to aerobic exercise training
(PT, n = 20) or to usual care (Control, n = 20). The training program consisted of lower and upper limb stretching
and 30 min of treadmill exercise, 3 times per week for a 6-week period. The improvement in submaximal performance
after exercise training was associated with parasympathetic activity.
4/10
Antonelli Incalzi
et al., 2009 [23]
We studied 54 patients with COPD. Heart rate variability (HRV) was assessed based on 24-h Holter ECG recording.
Sympathetic modulation decreased for increasing severity of COPD. In conclusion, drawing impairment correlates
with depressed sympathetic modulation in patients with COPD, and both might be indexes of COPD severity.
3/10
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vital capacity (FVC) in patients with COPD and demon-
strated that significant changes in HR, while on BP and
HRV it did not occurred the same changes. Throughout
the test, HR was undergoing changes as fall during the
beginning of the inspiratory phase of the test, followed
by an increase until the end of it, with the end of the in-
spiratory phase HR was reduced below the HR at rest
before resuming their baseline. During the expiratory
phase, HR was progressively increasing, the authors sug-
gested this to be related to the increased intrathoracic
pressure and decreased venous return, and reduction in
vagal activity and increased sympathetic activity that oc-
curs during expiration. When assessing the HRV, the ab-
sence of significant changes was verified, and the
authors highlighted the short duration of the maneuver,
the age of the volunteers and a probable autonomic dys-
function of individuals.
By analyzing the geometrical HRV indices, Dias de
Carvalho et al [17] illustrated decreased SD1, SD2,
TINN and RRtri in the COPD group, while the SD1/SD2
ratio were similar between the two groups. These findings
suggest a reduced HRV in patients with COPD. Reducing
the SD1 index indicates reduction in vagal activity of these
individuals, since the collapse in values of SD2, TINN and
RRtri in patients with the disease compared with healthy
subjects, indicating overall reduction in autonomic mo-
dulation of these individuals, which supports other studies
which indicated global autonomic damage in COPD.
Through the analysis of the Poincaré plot, the authors
found greater dispersion of data related to patients with
COPD, which, again, suggests the same reduced in HRV.
It was highlighted the importance of supervised exercise
in subjects with COPD, since the literature shows these
beneficial effects on cardiac autonomic modulation.
In a study by Dias de Carvalho et al [20], it was ana-
lyzed the properties of fractal correlation in patients with
COPD, with loss or breakdown of short-term fractal cor-
relation properties of HRV (alpha-1) associated with the
reduction of sympathetic and parasympathetic activity in
patients with COPD. According to the authors, patients
with COPD exhibit dynamic changes in HR indicating
loss of chaotic response. Equally, linear indexes in time
and frequency domain analyzed in the study illustrated a
reduction in sympathetic and parasympathetic activity in
volunteers of the COPD group compared to the control
group. The authors have attributed to this loss several
clinical events such as heart failure and acute myocardial
infarction. It was also suggested that individuals with
COPD exhibit autonomic dysfunction, indicated by the
loss of short-term fractal correlation properties and reduc-
tions in global activity of HRV, supporting the importance
of using these tools for evaluation of morbid states, be-
cause the ability to evaluate the loss of homeostasis of pa-
tients, allowing better discrimination between individuals
with or without physiological change. With respect to
long-term exponents (alpha-2) and alpha-1/alpha-2 ratio,
there was no difference between the COPD group and the
control group.
In order to analyze HRV after two exercise programs
in patients with COPD, Camillo and coworkers [19]
assessed 40 patients divided into two groups: high inten-
sity, characterized by endurance exercise and strength,
and of low intensity, that consisted of calisthenics and
breathing exercises for a period of 3 months. Cardiac
autonomic control was assessed before and after
3 months of training and, was judged during rest and as
a response to an orthostatic stimulus using a head-up tilt
test following a previous published protocol. Patients
were positioned on an orthostatic table where they ini-
tially stayed for 10 minutes in supine position. The table
was then lifted 75°, and this was followed by a period of
more 10 minutes in orthostatic position. The authors
concluded that three months of high-intensity exercise
training enable an important improvement in post-
training cardiac autonomic function in patients with
COPD. Additionally, better baseline values of upper
limbs muscle force, physical activity in daily life and total
heart rate variability may help predicting those patients
who will more likely improve their cardiac autonomic
function after a high-intensity exercise training program.
An important study [15] attempted to investigate the
effect of pulmonary rehabilitation on heart rate variabil-
ity during exercise in patients with COPD. Beyond, the
effect of pulmonary rehabilitation on health-related
quality of life and exercise capacity concurrently. Cardiac
autonomic control was measured with a total recording
time of 5 minutes at rest and at peak exercise and, were
obtained from the ECG signals. The protocol program
consisted of 12-week outpatient-based program with two
sessions per week. Before all training sessions, patients
went through prior educational training, then the lower
limb cycle ergometer exercise was performed. The train-
ing protocol of the lower limb exercise consisted of
warm up of 4 minute, followed by 60-100% peak VO2
for 40 minute and finally cool down of 4 minute. Work
rate, SpO2, HR, BP, dyspnea Borg’s scale, and leg fatigue
during the exercise training were monitored. They con-
cluded that patients with COPD often have impaired para-
sympathetic and sympathetic activity and poor exercise
capacity, and quality of life. Pulmonary rehabilitation pro-
vides significant improvement in HRV with concurrent
improvements in HRQL and exercise capacity.
In an attempt to investigate heart rate variability re-
sponses to a psychosocial stressor in COPD patients, and
the potential role of anxiety as a confounding factor in this
relationship, Suh and colleagues [16] analyzed four groups
of participants: COPD patients with elevated anxiety,
COPD patients without anxiety, healthy individuals with
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elevated anxiety, and healthy individuals without elevated
anxiety with 15 participants each. Participants performed
a test to check the level of anxiety and eligible completed
the pulmonary function test. The study was divided into
three phases: Baseline, Task, and Recovery. At Baseline, all
participants completed a packet of self-report question-
naires. Following the questionnaires, participants remained
sitting quietly for 5 minutes to obtain a stable measure of
heart rate variability at rest. During the Task phase, partici-
pants were exposed to the stressor task. A modified ver-
sion of the Trier Social Stress Test was used for this study.
And finally during the Recovery phase, each participant
completed a post-stressor questionnaire of state anxiety.
The participant then listened to relaxing music for 20 mi-
nutes. In this study the authors indicate that the combined
effect of anxiety and COPD did not have a cumulative
negative effect on autonomic function, contrary to the ori-
ginal hypothesis. However, an atypical pattern of HRV in
response to the stressor task for the COPD patients with
elevated anxiety and healthy individuals with elevated anx-
iety compared to their non-anxious counterparts suggests
that anxiety may play a mediating role in HRV patterns in
response to a stressor.
Hypothesizing that respiratory muscle weakness nega-
tively influences heart rate variability during respiratory
maneuvers in patients with COPD; Reis and coworkers
[26] aimed to evaluate the influence of respiratory muscle
strength on the magnitude of respiratory sinus arrhythmia.
All chronic obstructive pulmonary disease patients used
short-action bronchodilators, and six used long-action
bronchodilators. Subjects in the control group were free of
chronic pulmonary, cardiovascular, immune, and/or meta-
bolic disease. The volunteers were kept at rest in the su-
pine position for approximately 10 minutes to ensure that
a true resting HR value was achieved. Then, the ECG sig-
nal and the instantaneous HR were obtained at rest in the
supine position for 15 minutes. Subsequently, the heart
rate and RR intervals were recorded during the respiratory
sinus arrhythmia maneuver in the supine position in the
following order: for one minute at rest with spontaneous
breathing; for four minutes while performing the respira-
tory sinus arrhythmia maneuver; and for one minute at
rest with spontaneous breathing. It was concluded that
COPD patients showed evidence of impaired autonomic
modulation of heart rate at rest and during respiratory
sinus arrhythmia maneuver, the relationship between the
maximal inspiratory pressure and heart rate variability
indices during respiratory sinus arrhythmia maneuver
indicates that the inspiratory muscle weakness observed
in this population may be associated with cardiac auto-
nomic control.
The aim of the study by Borghi-Silva and coworkers [22]
was to assess the impact of an aerobic exercise program
on autonomic modulation in patients with moderate-to-
severe COPD. Forty patients of both sexes were included
in the study and all of them received regular treatment
consisting of inhaled bronchodilators and steroids and
none of them were prescribed oral steroids, antibiotics, an-
tihypertensive or beta-blockers. Heart rate variability data
were collected during 10 minutes of rest and throughout
the six-minute walk test. Aiming to maintain peripheral
oxygen saturation greater than 90%, four patients of the
experimental group and three patients in control group re-
ceived supplemental oxygen. Concluding, the study dem-
onstrates that a 6-week aerobic exercise training program
leads to an improvement in exercise tolerance, promotes
ventilator and physiological adaptations and favorably
impacts the derangements in autonomic modulation of
heart rate both at rest and during exercise in patients
with COPD.
A group of Italian researchers [23] studied 54 patients
with hypoxemic chronic obstructive pulmonary disease.
Neuropsychological assessment was performed by The
Mini Mental State Examination and the Mental Deterior-
ation Battery and heart rate variability was assessed based
on 24-hour Holter ECG recording. It was observed by the
researchers, a correlation between drawing impairment
and depressed sympathetic modulation of the neuroau-
tonomic tone. Such a relationship seems worthy of re-
assessment in a larger and more heterogeneous COPD
population in the framework of properly designed stud-
ies including also a well balanced set of executive and
copying tests. Confirming or denying present findings
would make physicians aware of whether a further di-
mension should be added to the many characterizing
COPD as a systemic disease.
An important study of Van Gestel and co-workers [13]
aimed to evaluate whether there is an association be-
tween cardiac autonomic dysfunction and health-related
quality of life in COPD patients. They applied a six-
minute walk test in all patients and performed on a 30
metre indoor track using standardized encouragement
strategy. Breathlessness and leg fatigue were assessed
using a conventional Borg scale in German. Analysis of
heart rate variability was performed using a Holter-ECG
device for a recording period of 5 minutes, with the
patients at rest, sitting on a chair. Cardiac autonomic
function was performed 30 minutes after pulmonary
function was assessed during the midday between
11:00 –15:00. The study shows that resting parasympa-
thetic tone, as measured by HRV, is independently as-
sociated with health-related quality of life emphasizing
the role of cardiac autonomic dysfunction on health-
related quality of life in patients with COPD. Modifica-
tion of cardiac autonomic dysfunction may therefore
be of benefit in the treatment of COPD patients, but
this needs to be proven in controlled interventional
trials.
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Gunduz and colleagues [14] also analyzed the presence
of autonomic dysfunction in patients with COPD by
heart rate variability and heart rate turbulence analysis
and to determine whether the parameters of these in this
population are different from the normal population.
Spirometric and blood tests were performed in all partic-
ipants and heart rate variability was assessed by 24-hour
Holter monitoring. In the view of authors, the combin-
ation of heart rate variability and heart rate turbulence
variables may be simple and elegant ways of evaluating
cardiac autonomic functions. Such a combination may
increase the positive predictivity and lead to a more ac-
curate identification of high risk patients, more aggres-
sive treatment towards preventing sudden death and/or
preventing progression of disease to mortality.
By analyzing the studies eligible for our review, unfor-
tunately, we found poor methodological quality of most
of them, according to the PEDro scale [11]. We observed
that 36% of them had score 3, 27.5% score 4, 27.5% score
5, and only one study with score 6, considered with good
methodological quality; it should be emphasized that
better designed studies can better represent proposed
objectives by their results.
Thus, HRV is an important tool for assessing the auto-
nomic nervous system (ANS), which has an important role
in maintaining homeostasis. Its use is diverse and it stands
as a predictor of the internal functions of the body, both in
normal and pathological conditions, characterizing current
instrument evaluation and identification of problems in
the health, growth and human development [27]. Health
care is conventionally regarded as the diagnosis, treatment,
and prevention of disease, illness, injury, and other physical
and mental impairments in humans. How we define the
quality of public health at any given time must be compa-
tible with future generations enjoying health in an equiva-
lent way [28].
Conclusion
We present in this review studies that focused on the
behavior of the HRV in patients with COPD during in-
terventions, such as, respiratory sinusal arrhythmia man-
euver, non-invasive ventilation, among others. These
data show the importance of HRV as low cost method
for early diagnosis of cardiovascular diseases concomi-
tant with lung diseases, since these diseases tend to co-
exist influencing on morbidity and mortality of these
patients. It is well known that COPD patients tend to
have a reduced HRV, and consequently deterioration of
symptoms. These studies attempt to show the import-
ance of interventions that help to minimize the effects
that COPD may lead in these patients.
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